{
    "nctId": "NCT01505400",
    "briefTitle": "Integrated Molecular Profiling in Advanced Cancers Trial",
    "officialTitle": "Integrated Molecular Profiling in Advanced Cancers Trial",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Genitourinary Cancer, Pancreatobiliary Gastrointestinal Cancer, Upper Aerodigestive Tract Cancer, Gynecological Cancers, Melanoma Cancers, Rare Cancers, Unknown Primary Cancers",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 3026,
    "primaryOutcomeMeasure": "Molecular profiling data to be made available in patient's electronic medical records.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histological confirmation of advanced breast, non-small cell lung, colorectal, genitourinary, pancreatobiliary gastrointestinal, upper aerodigestive tract, gynecological, melanoma, unknown primary, and rare carcinomas who are candidates for systemic therapy, as well as patients who are phase I trial candidates.\n* Patient must be \u2265 18 years old.\n* Patient's ECOG performance status equal to 0 or 1.\n* All patients must have signed and dated an informed consent form.\n* All patients must have sufficient archived tumor tissue for molecular profiling.\n\nExclusion Criteria:\n\n* None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}